TY  - GEN
AU  - Hamada,Toshihisa
AU  - Sugaya,Makoto
AU  - Tokura,Yoshiki
AU  - Ohtsuka,Mikio
AU  - Tsuboi,Ryoji
AU  - Nagatani,Tetsuo
AU  - Tani,Mamori
AU  - Setoyama,Mitsuru
AU  - Matsushita,Shigeto
AU  - Kawai,Kazuhiro
AU  - Yonekura,Kentaro
AU  - Yoshida,Tsuyoshi
AU  - Saida,Toshiaki
AU  - Iwatsuki,Keiji
TI  - Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas
SN  - 1346-8138
PY  - 2018///0314
KW  - Adult
KW  - Aged
KW  - Anticarcinogenic Agents
KW  - pharmacokinetics
KW  - Bexarotene
KW  - Female
KW  - Humans
KW  - Lymphoma, T-Cell, Cutaneous
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Retinoid X Receptors
KW  - agonists
KW  - Tetrahydronaphthalenes
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/1346-8138.13542
ER  -